Curis | CRIS - Current Liabilities


Curis reported $14.08M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 595K 218K Mar/2026
Amgen USD 24.96B 534M Mar/2026
AstraZeneca USD 32.57B 1.95B Mar/2026
Bayer EUR 33.46B 875M Mar/2026
Bristol-Myers Squibb USD 19.16B 4.26B Mar/2026
CSL USD 4.61B 207M Dec/2025
Curis USD 14.08M 5.3M Dec/2025
Eli Lilly USD 36.63B 1.41B Mar/2026
Exelixis USD 370.98M 34.67M Mar/2026
Gilead Sciences USD 9.48B 2.34B Mar/2026
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
Incyte USD 1.49B 25.52M Mar/2026
Merck USD 26.94B 1.38B Mar/2026
Novartis USD 31.37B 4.1B Mar/2026
Pfizer USD 34.35B 2.64B Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
Takeda JPY 2.43T 180.65B Mar/2026
TG Therapeutics USD 187.11M 33.35M Mar/2026
Verastem USD 72.27M 12.56M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025